Growth Differentiation Factor 15 Is Associated with Platelet Reactivity in Patients with Acute Coronary Syndrome.
acute coronary syndrome
growth differentiation factor 15
platelet reactivity
prasugrel
ticagrelor
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
17 Feb 2023
17 Feb 2023
Historique:
received:
30
12
2022
revised:
01
02
2023
accepted:
15
02
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
26
2
2023
Statut:
epublish
Résumé
Bleeding events in patients with acute coronary syndrome (ACS) are a risk factor for adverse outcomes, including mortality. We investigated the association of growth differentiation factor (GDF)-15, an established predictor of bleeding complications, with on-treatment platelet reactivity in ACS patients undergoing coronary stenting receiving prasugrel or ticagrelor. Platelet aggregation was measured by multiple electrode aggregometry (MEA) in response to adenosine diphosphate (ADP), arachidonic acid (AA), thrombin receptor-activating peptide (TRAP, a protease-activated receptor-1 (PAR-1) agonist), AYPGKF (a PAR-4 agonist) and collagen (COL). GDF-15 levels were measured using a commercially available assay. GDF-15 correlated inversely with MEA ADP (r = -0.202,
Identifiants
pubmed: 36836162
pii: jcm12041627
doi: 10.3390/jcm12041627
pmc: PMC9966081
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Medical Scientific Fund of the Mayor of the City of Vienna
ID : 14016
Organisme : Anniversary Fund of the Austrian National Bank
ID : 16155
Organisme : Austrian Heart Fund
ID : 202003
Références
Circulation. 2016 Sep 6;134(10):e123-55
pubmed: 27026020
J Cardiovasc Pharmacol Ther. 2022 Jan-Dec;27:10742484221096524
pubmed: 35482903
Semin Thromb Hemost. 2017 Sep;43(6):621-628
pubmed: 28597461
Eur Heart J. 2019 Jan 7;40(2):87-165
pubmed: 30165437
Platelets. 2022 Feb 17;33(2):249-256
pubmed: 33760697
N Engl J Med. 2007 Nov 15;357(20):2001-15
pubmed: 17982182
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
Free Radic Biol Med. 2020 Mar;149:64-71
pubmed: 31926293
J Hepatol. 2017 May;66(5):1047-1081
pubmed: 28417882
Nat Med. 2017 Oct;23(10):1150-1157
pubmed: 28846097
Cardiovasc Ther. 2013 Oct;31(5):e40-5
pubmed: 23311679
N Engl J Med. 2009 Sep 10;361(11):1045-57
pubmed: 19717846
J Am Coll Cardiol. 2009 Mar 10;53(10):849-56
pubmed: 19264241
Nat Med. 2011 May;17(5):581-8
pubmed: 21516086
J Am Coll Cardiol. 2014 Sep 2;64(9):863-71
pubmed: 25169169
Cardiovasc Diabetol. 2016 Apr 08;15:60
pubmed: 27056183
Atherosclerosis. 2009 Dec;207(2):608-13
pubmed: 19616779
BMC Med. 2019 Nov 4;17(1):198
pubmed: 31679516
Eur Heart J. 2018 Jan 14;39(3):213-260
pubmed: 28886622
J Thromb Haemost. 2013 Feb;11(2):335-44
pubmed: 23231375
J Clin Med. 2020 Jul 01;9(7):
pubmed: 32630233
Eur Heart J. 2016 Apr 21;37(16):1325-33
pubmed: 26417057
J Thromb Haemost. 2010 Feb;8(2):250-6
pubmed: 19943882
Thromb Haemost. 2006 Dec;96(6):781-8
pubmed: 17139373
JACC Cardiovasc Interv. 2019 Aug 26;12(16):1521-1537
pubmed: 31202949
Eur Heart J. 2022 Mar 07;43(10):959-967
pubmed: 34918066
Circulation. 2014 Nov 18;130(21):1847-58
pubmed: 25294786
Res Pract Thromb Haemost. 2018 May 27;2(3):439-449
pubmed: 30046748
Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11514-9
pubmed: 9326641
Lancet. 2022 Apr 2;399(10332):1347-1358
pubmed: 35367005
Thromb Haemost. 2014 Mar 3;111(3):474-82
pubmed: 24196591
Pharmaceuticals (Basel). 2022 Apr 15;15(4):
pubmed: 35455481
Int J Cardiol. 2013 Jun 5;166(1):126-31
pubmed: 22075408
Eur Heart J. 2023 Jan 21;44(4):293-300
pubmed: 36303404
Nat Med. 2020 Aug;26(8):1264-1270
pubmed: 32661391
Int J Cardiol. 2018 Dec 15;273:29-33
pubmed: 30228021